Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 5, Pages 1458
Publisher
MDPI AG
Online
2020-05-14
DOI
10.3390/jcm9051458
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of prior antibiotic use on the efficacy of nivolumab for non‑small cell lung cancer
- (2019) Taiki Hakozaki et al. Oncology Letters
- Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors
- (2019) Arielle Elkrief et al. OncoImmunology
- Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer
- (2019) Sha Zhao et al. LUNG CANCER
- Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer
- (2019) Giulia Galli et al. LUNG CANCER
- Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer
- (2019) Nadina Tinsley et al. ONCOLOGIST
- Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab
- (2019) Julia Ouaknine Krief et al. Journal for ImmunoTherapy of Cancer
- Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade
- (2019) Huemer et al. Journal of Clinical Medicine
- Neutrophil–to–lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
- (2019) JHE-CYUAN GUO et al. ANTICANCER RESEARCH
- Gut microbiota and cancer: how gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy
- (2019) Stefania Gori et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Antibiotic use and the efficacy of immune checkpoint inhibitors in cancer patients: a pooled analysis of 2740 cancer patients
- (2019) Xuan-Zhang Huang et al. OncoImmunology
- Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
- (2019) David J. Pinato et al. JAMA Oncology
- Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
- (2019) Hamzah Abu-Sbeih et al. Journal for ImmunoTherapy of Cancer
- Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
- (2018) L Derosa et al. ANNALS OF ONCOLOGY
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer
- (2018) Florian Huemer et al. Oncotarget
- Cumulative antibiotic use and efficacy of immune checkpoint inhibitors in patients with advanced cancer.
- (2018) Nadina Tinsley et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors
- (2018) Jibran Ahmed et al. OncoImmunology
- Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials
- (2018) S Sen et al. ANNALS OF ONCOLOGY
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now